arrow
B

Bob van de Water

Leiden Academic Center for Drug Research
H指数:61
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Systematic assessment of transcriptomic and phenotypic biological profiling for mechanism-based hazard assessment using target-annotated reference chemicals in renal proximal tubular epithelial cells

基于靶向注释参考化学品的肾近端小管上皮细胞转录组学和表型生物学谱的系统评估,用于机制基础的危害评估

2026-10-310
OAAI
Correction: Applicability of NAMs to support a read-across based hazard assessment workflow for systemic toxicity: a conazole case study

更正:NAMs在支持基于读越法的全身毒性危害评估工作流程中的应用:以唑类化合物为例

2026-10-210
OAAI
Analytical choices drive toxicogenomic potency estimates: a systematic evaluation of transcriptomic points of departure

分析选择驱动毒理基因组学效力估计:转录组学起始点的系统评价

2026-09-080
OA
Disrupting CDK9 activity suppresses triple-negative breast cancer and is enhanced by EGFR Inhibition

抑制CDK9活性可抑制三阴性乳腺癌,且该抑制作用可被EGFR抑制增强

2026-01-080
OAAI
Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety

定量系统毒理学: 建模以机械地理解和预测药物安全性

2025-10-270
PRE
The Long Way from Raw Data to NAM-Based Information: Overview on Data Layers and Processing Steps

从原始数据到NAM(名称)基础信息的漫长路径:数据层和加工步骤概述

2025-01-013
OA
ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells

通过基因座扩增的ABCB1过表达代表了对抗胰腺癌细胞中紫杉醇耐药性的可行靶标

2024-01-0211
OAAI